S
Sean Pinney
Researcher at University of Chicago
Publications - 231
Citations - 6762
Sean Pinney is an academic researcher from University of Chicago. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 35, co-authored 187 publications receiving 4711 citations. Previous affiliations of Sean Pinney include Cardiovascular Institute of the South & Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Recurrence of eosinophilic granulomatosis with polyangitis after orthotopic heart transplant.
TL;DR: A case of a Caucasian woman successfully bridged to heart transplantation with a continuous flow left ventricular assist device (LVAD) who survived recurrence of EGPA in the allograft.
Journal ArticleDOI
MOGE(S) nosology in low-to-middle-income countries.
Eloisa Arbustini,Navneet Narula,G. William Dec,K. Srinath Reddy,Barry H. Greenberg,Sudhir S. Kushwaha,Thomas H. Marwick,Sean Pinney,Riccardo Bellazzi,Valentina Favalli,Christopher M. Kramer,Robert Roberts,William A. Zoghbi,Robert O. Bonow,Luigi Tavazzi,Valentin Fuster,Jagat Narula +16 more
TL;DR: In a very thoughtful News and Views article, Professor Mayosi described MOGE(S) as an “admirable achievement on the path towards a globally accepted nomen clature for cardiomyopathy” and suggested that an MOGS(S), nosology in low-to-middle-income countries, is needed.
Journal ArticleDOI
Association of Infections in Patients Supported with Left Ventricular Assist Device with Vasoplegia and Post-Cardiac Transplant Outcomes
Michael Halista,Aditya Parikh,Donna M. Mancini,Sumeet S. Mitter,Maya H. Barghash,Maria Giovanna Trivieri,Johanna Contreras,Sarah Taimur,Julie Roldan,Joseph Murphy,Amit Pawale,Anelechi C. Anyanwu,Sean Pinney,N. Moss,Anuradha Lala +14 more
TL;DR: In this cohort, LSI were common among LVAD patients but not associated with vasoplegia or the clinical outcome of ARF, graft rejection, or mortality in the first year post HT, which may be limited by a small sample size.
Journal ArticleDOI
Sodium Glucose Co-Transporter 2 Inhibitor Use in Patients with Left Ventricular Assist Devices
M. E. Acosta,Mark N. Belkin,Pamela Simone,Viktoriya Kagan,C. Juricek LaBuhn,Karen Meehan,J. Okray,Anh Nguyen,Ben Chung,Jonathan Grinstein,B.A. Smith,Sara Kalantari,Nitasha Sarswat,Valluvan Jeevanandam,Sean Pinney +14 more
TL;DR: In this article , the authors evaluated the use of SGLT2 inhibitors in patients with heart failure with reduced ejection fraction (HFrEF) in the Left Ventricular Assist Device (LVAD) population.
Journal ArticleDOI
Enhancing Palliative Care for Patients With Advanced Heart Failure Through Simple Prognostication Tools: A Comparison of the Surprise Question, the Number of Previous Heart Failure Hospitalizations, and the Seattle Heart Failure Model for Predicting 1-Year Survival
TL;DR: SQ and NoH yielded comparable utility to SHFM for 1-year survival prediction among advanced HF patients, are easy-to-use and could inform bedside decision-making.